0.1578SEK+12.71%Mkt Cap: 64.65M SEKP/E: —Last update: 2026-06-01
SpectraCure AB (publ) engages in the development of cancer treatment system in Sweden. It develops Q-PRO, a laser unit; IDOSE software platform, which calculates the optimal laser light dose and placement of the optical …
Industry Peers
Medical Devices152.01BUSDP/E 24.4
115.59BUSDP/E 34.9
71.08BUSDP/E 20.0
54.41BSEKP/E 101.6
52.05BDKKP/E 22.0
51.03BUSDP/E 47.9
50.55BSEKP/E 21.4
38.34BEURP/E 18.1
Indicators:|
Key Statistics
Company
Market Cap64.65M SEK
Enterprise Value46.62M SEK
Revenue (TTM)649.00K SEK
Gross Profit12.44M SEK
Net Income (TTM)-56.08M SEK
Revenue/Share0.0070 SEK
Last Price0.1578 SEK
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees13
CountrySE
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-3.12
EV/Revenue71.83
P/S88.37
P/B0.57
EPS (TTM)-0.20
EPS (Forward)—
52W Range
0.05839% of range1.192
52W High1.192 SEK
52W Low0.0583 SEK
Profitability
Gross Margin618.85%
Oper. Margin-916.59%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-59.94%
ROA-53.68%
Growth
Revenue Growth-43.30%
Earnings Growth—
Cash Flow & Leverage
Operating CF-24.03M SEK
CapEx (TTM)19.64M SEK
FCF Margin—
FCF Yield—
Net Debt-10.74M SEK
Net Debt/EBITDA0.72
Balance Sheet
Debt/Equity0.03
Current Ratio7.02
Quick Ratio6.91
Book Value/Sh0.2470 SEK
Cash/Share0.0330 SEK
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 SEK
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.409.67M
Float336.20M
Insiders14.83%
Institutions2.35%
Technical
SMA 500.0801 (+97.0%)
SMA 2000.1345 (+17.3%)
Beta—
S&P 52W Chg27.70%
Avg Vol (30d)2.64M
Avg Vol (10d)3.29M
Technical Indicators
RSI (14)87.1
MACD0.0112
MACD Signal0.0030
MACD Hist.+0.0081
BB Upper0.1245 SEK
BB Middle0.0792 SEK
BB Lower0.0340 SEK
BB Width114.29%
ATR (14)0.0141 SEK
Vol Ratio (20d)2.78x